Latest COPD Information from The COPD Foundation

Latest COPD Information from The COPD Foundation http://www.COPDFoundation.org/COPDProviders/ Latest COPD Information from The COPD Foundation http://blogs.law.harvard.edu/tech/rss en-us Matthew1471's BlogX / BlogX.co.uk Copyright 2007-2008 - COPDFoundation.org webmaster@COPDFoundation.org (cg) webmaster@COPDFoundation.org (cg) http://www.COPDFoundation.org/COPDProviders/RSS/Image.jpg Latest COPD Information from The COPD Foundation http://www.COPDFoundation.org/COPDProviders/ 100 100 Sun, 8 Apr 2008 14:47 EST Regional Symposiums and National Teleconference Series on COPD http://www.COPDFoundation.org/COPDProviders/ViewItem.asp?Entry=194 http://www.COPDFoundation.org/COPDProviders/Comments.asp?Entry=194 Regional Symposiums and National Teleconference Series on the Evolving Issues in Assessment and Management of COPD This educational series will be discussing current issues in COPD management through case presentation. The following issues will be cover... Tue, 3 Apr 2008 19:45 EST Alpha-1 and COPD Foundations Sponsor Workshop on Standardizing CT Scans for COPD http://www.COPDFoundation.org/COPDProviders/ViewItem.asp?Entry=193 http://www.COPDFoundation.org/COPDProviders/Comments.asp?Entry=193 The Alpha-1 Foundation and COPD Foundation are sponsoring a workshop this week for specialists from around the world to review the state of the art in CT Scan technology and arrive at a set of recommendations for future research on COPD. The two-day wor... Sun, 29 Mar 2008 11:53 EST Ventilators and diaphragm disuse contributes to muscle atrophy http://www.COPDFoundation.org/COPDProviders/ViewItem.asp?Entry=192 http://www.COPDFoundation.org/COPDProviders/Comments.asp?Entry=192 A new study by University of Pennsylvania School of Medicine shows, for the first time in humans, that ventilators combined with diaphragm disuse contributes to muscle atrophy in the diaphragm in as little as eighteen hours. Muscle atrophy in the diaph... Sun, 29 Mar 2008 11:50 EST Reduced Lung Capacity Accelerates With Diabetes http://www.COPDFoundation.org/COPDProviders/ViewItem.asp?Entry=191 http://www.COPDFoundation.org/COPDProviders/Comments.asp?Entry=191 People who have diabetes encounter a faster loss of lung capacity than those who do not have diabetes, Specifically, the study found that people with type 2 diabetes experienced a more rapid decline in forced vital capacity, the measure of how well the ... Tue, 24 Mar 2008 09:23 EST New drug combination may have significant savings. http://www.COPDFoundation.org/COPDProviders/ViewItem.asp?Entry=190 http://www.COPDFoundation.org/COPDProviders/Comments.asp?Entry=190 Cipla is set to launch the world's first triple drug combination inhaler for COPD patients in India. Cipla's brand, Triohale will have triotropium, formoterol and ciclesonide for asthma patients. The company is in the process of registering the drug for ex... Thu, 19 Mar 2008 10:32 EST Tiotropium (Spiriva) Alert from the FDA http://www.COPDFoundation.org/COPDProviders/ViewItem.asp?Entry=189 http://www.COPDFoundation.org/COPDProviders/Comments.asp?Entry=189 Based on data from 29 placebo-controlled trials of tiotropium (Spiriva), Boehringer Ingelheim and the FDA has alerted Pulmonary Healthcare professionals and patients that ongoing safety monitoring has identified a possible increased risk of stroke in patie... Tue, 3 Mar 2008 08:51 EST Google Unveils New Medical Support Service http://www.COPDFoundation.org/COPDProviders/ViewItem.asp?Entry=188 http://www.COPDFoundation.org/COPDProviders/Comments.asp?Entry=188 Google Inc. has unveiled a plan to help U.S. patients gain control of their medical records. They have been working with doctors' groups, pharmacies and laboratories to help them securely share sensitive health data. The Web service will store health ... Thu, 19 Feb 2008 18:09 EST Phase II trial to start for BIO-11006 http://www.COPDFoundation.org/COPDProviders/ViewItem.asp?Entry=187 http://www.COPDFoundation.org/COPDProviders/Comments.asp?Entry=187 The drug development firm BioMarck said Monday that it has received clearance from the U.S. Food and Drug Administration to launch a Phase II clinical trial for its compound that targets chronic obstructive respiratory disease, or COPD. The Phase II tri... Wed, 18 Feb 2008 08:26 EST Methodological Advances in Detection of emphysema progression in alpha 1 http://www.COPDFoundation.org/COPDProviders/ViewItem.asp?Entry=186 http://www.COPDFoundation.org/COPDProviders/Comments.asp?Entry=186 Abstract Background: Computer tomography (CT) densitometry is a potential tool for detecting the progression of emphysema but the optimum methodology is uncertain. The level of inspiration affects reproducibility but the ability to adjust for this vari... Sat, 14 Feb 2008 08:24 EST Phase II Clinical Trials of AAT Product For The Treatment Of Bronchiectasis http://www.COPDFoundation.org/COPDProviders/ViewItem.asp?Entry=185 http://www.COPDFoundation.org/COPDProviders/Comments.asp?Entry=185 Kamada (TASE:KMDA), a biopharmaceutical company which develops, manufactures and markets specialty life-saving therapeutics, announces that the company will soon start phase II clinical trials with the inhaled version of its Alpha-1 Antitrypsin (AAT) produ...